2020 was a year like no other. Since March 2020 conferences and events have rightfully been cancelled or postponed across the world, including our Annual International CytoSorb Users Meeting. So we challenged ourselves to come up with something that could to some extend replace the live event.
In this study, clinical researchers at Maasstad Hospital and at Erasmus University Medical Center in Rotterdam, Netherlands conducted a retrospective evaluation of 116 patients with septic shock, who required vasopressors to increase their blood pressure, and renal replacement therapy (RRT) due to kidney failure.
According to the current definition, sepsis is a life-threatening organ dysfunction due to a dysregulated body response to an infection. This systemic infection can be caused by bacteria, fungi or even viruses.
“Our collaboration with CytoSorbents enables us to offer this innovative, easy-to-use blood purification therapy to address our customers’ most challenging cardiac cases,” stated Arik Anderson, President of Perfusion and Surgical Devices Division at Terumo. “CytoSorb integrates with the heart-lung machine platform, giving surgical teams, for the first time, the ability to safely reduce dangerous inflammatory mediators in real-time as they are being generated during cardiac surgery.”
“However, whether it is a newer innovation in imaging, dialysis therapy, mechanical ventilation or circulatory support, nothing has really moved the needle in terms of improved clinical outcomes. These are mainly supportive care technologies that keep the patient alive until they can recover on their own,” said Halpern.
The therapy of severe blood poisoning – termed Sepsis – is one of the specialties of intensive care at the Klinikum Emden. The Department of Anaesthesiology and Intensive Care Medicine under the direction of chief physician Dr. med. Klaus Kogelmann has long been represented at international congresses with his own work and together with the German working group SepNet (Competence Network Sepsis). For example, at the 7th International Sepsis Congress in Weimar in September, a presentation on the subject of “Blood purification in sepsis” (Cytosorb) was presented.
The Department of Anaesthesiology, Anesthesiological Intensive Care and Perioperative Pain Management under the direction of Privatdozent Dr. med. med. Gerd Albuszies, MBA in the GPR Clinic, is now using a new therapy method in the intensive care unit of the GPR Clinic, which is used in a massive inflammatory reaction of the body (inflammatory cytokine release) in sepsis.
Every year, up to 20 million people worldwide die of sepsis. That’s up to 13% more than ten years ago. Today, more people are dying of sepsis than total prostate and breast cancer and HIV / AIDS combined.
Blood poisoning is one of the leading causes of death in Germany. The Bramscher Niels Stensen clinics are now working as one of the first homes in the region with a new method that helps fight blood poisoning as early as possible and save human lives.
Mr. Vincent Capponi, Chief Operating Officer of CytoSorbents stated, „I am happy to announce CytoSorbents successfully completed its CE Mark and ISO13485:2016 re-certification audits. These certificates cover CytoSorb and our new manufacturing facility commissioned in June 2018. The success of this renewal of the CE Mark and recent audit is a reflection of CytoSorbents‘ ongoing commitment to quality. I am very proud of our quality, manufacturing, and research teams that contributed to these accomplishments.“
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, expands CytoSorb distribution to Brazil, Colombia and Costa Rica, with Contatti Medical, Service & Medical Colombia, and Nutricare Costa Rica, respectively.
One day ahead of the 39th International Symposium of Intensive Care and Emergency Medicine (ISICEM), CytoSorbents invited for its 6th International CytoSorb Users Meeting at the Square Meeting Center in Brussels, Belgium.
On the eve of the 18th DIVI 2018 in Leipzig, CytoSorbents invited to the 5th German-speaking CytoSorb user meeting. An excellent speaker panel presented in Leipzig new data and insights on the following topics …
Just prior to the 38th ISICEM conference, CytoSorbents held its 5th International CytoSorb Users Meeting, relocating to the larger ISICEM conference center from the Hotel Marivaux in years past, to accommodate nearly 150 participants from the growing global CytoSorb community, including physicians, partners, and distributors.
The 28th Symposium Intensive Care + Intensive Care took place in Bremen from 14.-16.02.2018. Among the 4,726 congress participants…
The 4th German-speaking CytoSorb user meeting 2017 took place on the eve of the 17th DIVI 2017 in Leipzig. An excellent speaker panel presented new data and insights on the following topics ..
During your daily work at the patients’ bedside or when doing research in preparation for a lecture or a publication, you would love to gather a broad overview of the available literature surrounding CytoSorb therapy.
The Roger-Bone-Prize for clinical sepsis research, selected by the German Sepsis Society, is awarded every year to young scientists from German speaking countries.
